Cardinal Health $1.12 billion acquisition of Harvard Drug Group

Overview:

• Cardinal Health has completed its $1.12 billion acquisition of the Harvard Drug Group.
• Harvard Drug Group distributes generic and over-the-counter medications, and was sold by private equity firm Court Square Capital Partners.
• The deal was announced just over a month ago, on June 5 2015.
• Jones Day (Andrew Levine, Timothy FitzSimons) advised Cardinal Health.
• Dechert (Craig Godshall, Richard Wild, Susan Hendrickson) advised Harvard Drug Group.

Kurt Stumpo - Journalist - North America and the Caribbean